openPR Logo
Press release

Erectile Dysfunction Devices Market - Global Industry Insights,Outlook, and Opportunity Analysis, 2016-2024

06-19-2017 04:46 PM CET | Health & Medicine

Press release from: CMI - Research

Erectile Dysfunction Devices Market - Global Industry

Erectile Dysfunction Devices Market Overview

Erectile dysfunction (ED) also known as impotence, is the inability to get an erection during sexual intercourse. It is a common medical condition in men. Though less common among the younger age group, erectile dysfunction affects 5%–10% of men under 40 years of age. A recent study published in the Journal of Sexual Medicine revealed that one in four patients who sought medical help for erectile dysfunction are under the age of 40 years. Men undergoing cardiovascular or diabetes treatment are at higher risk of developing erectile dysfunction. The condition is strongly related to physical and psychological health. Treatment options include ED drugs, injectable, penile implants, surgery, and vacuum constriction devices. Usually medications such as Sildenafil, Tadalafil, Vardenafil, Avanafil, Alprostadil, and Udenafil are prescribed to treat erectile dysfunction. However, a very small percentage of men are aware of the prevalence of the condition and lower still are the number of people who opt to consult an urologist about it, mainly due to social stigma attached to it. As per a study conducted by the European Association of Urology, only 25% of the men estimated to be suffering from the condition seek medical treatment.

Request for an exclusive sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/27

Wide availability of advanced technology devices drives growth of erectile dysfunction devices market

The global erectile dysfunction devices market can be analyzed on the basis of type of device and geography. On the basis of type of device, the global erectile dysfunction devices market is classified as vacuum pumps, penile implants (internal penile pump/inflated pump), vibrators, ED rings, and medicated urethral system (MUSE). Some of the major bands available in the market are Erektor, Viberect, SomaTherapy-ED, Encore, Bonro Medical, and Vacurect.

Vacuum pump, also known as Vacuum Erection device (VED), requires no medication or surgery and is also reimbursed in the U.S. According to the National Health Services, nine out of ten men using vacuum pumps are able to have sex regardless of the underlying cause of ED. Penile implants are medicated devices, which further requires research on its efficacy and safety.

Alternative treatment options hindering growth of erectile dysfunction devices market

Wide availability of effective OTC oral medication such as Viagra adversely impacts demand for erectile dysfunction devices. Also, lack of awareness about proper usage of these devices and pain associated with use, inhibit the growth of erectile dysfunction devices market. Besides, alternative treatment options such as low-intensity extracorporeal shockwave therapy, herbal medicines, and lifestyle changes also limit the demand for ED devices. New technologies such as tissue engineering and nanotechnology are being explored to develop more effective solutions for treatment of erectile dysfunction.

Get discount on this report by CMI @ https://www.coherentmarketinsights.com/insight/request-discount/27

Regional Analysis of Erectile Dysfunction Devices Market

America, Europe, Asia Pacific, Latin America, Africa, and Middle East are major global markets for erectile dysfunction devices. Growing prevalence of ED, increasing awareness about treatment, and high disposable income in developed regions propel the growth of erectile dysfunction devices market. Major marketing activities carried out by various players in the market have contributed largely in creating awareness among the population. However, various device types and their advantages are still not known to healthcare professionals, which in turn results in lower adoption among the general population.

Key Players involved in the erectile dysfunction devices market

There are many regional players operating in this market owing to low entry and exit barriers. Being class 1 and 2 devices and fueled by increasing awareness levels, various players are entering this market. Some of the major players in the global erectile dysfunction devices market are Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical Systems, and Boston Scientific Corporation.

Browse Full Report: https://www.coherentmarketinsights.com/ongoing-insight/erectile-dysfunction-devices-market-27

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erectile Dysfunction Devices Market - Global Industry Insights,Outlook, and Opportunity Analysis, 2016-2024 here

News-ID: 585500 • Views:

More Releases from CMI - Research

Global Generic Sterile Injectable Market - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Generic Sterile Injectable Market - Insights, Size, Share, Opportunity An …
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable. Apart from prevalence of chronic diseases, several other factors that are responsible to fuel the
Global Intravenous Access Devices Market - Catheters (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters, Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Intravenous Access Devices Market - Catheters (Midline Peripheral Cathete …
Rising incidence of cardiovascular disease due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for intravenous access device around the globe. According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Le …
According to the American Society of Hematology, in 2016, prevalence of MDS ranged from 0.22-13.2 per 100,000, on all age categories and ethnicities globally. Increasing public awareness about the disease and introduction of new treatment for MDS will drive the growth of the market. Furthermore, growing aging population is analyzed to be a major factor propelling the growth of myelodysplastic syndrome treatment market. According to NCBI, 2012, the incidence of
Global Multiplexed Diagnostic Market by Product Type Reagents & Consumables and Instruments - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Multiplexed Diagnostic Market by Product Type Reagents & Consumables and …
The multiplexed diagnostic market is gaining significant traction due to the rising prevalence of autoimmune diseases. According to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015, was estimated in 54 million U.S adults (22.7%) and by 2040, it is expected to be 78 million (26%) U.S adults age 18 years or older. The data represent the high prevalence of autoimmune diseases, indicating

All 5 Releases


More Releases for Erectile

Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco
50 Open Clinical Studies Presently, To Treat Erectile Dysfunction To Boost The E …
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a ratio
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Request for Sample of This Research Report @ https://bit.ly/2NXzatD Top Key Players:- Bayer AG Pfizer Eli Lilly & Co. Vivus, Inc. S.K. Chemicals Co. Ltd. Dong-A Pharmaceutical Co. Ltd Meda Pharmaceuticals Apricus Biosciences Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying According to a new study published by Polaris Market Research the global erectile dysfunction
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction: A Prominent Age Related Disorder
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a
Erectile Dysfunction - Pipeline Review, H2 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Erectile Dysfunction - Pipeline Review, H2 2017”. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1246564 The predisposing factors include tobacco usage, overweight, injuries, drug and alcohol use and medications, including antidepressants,